View in EDS HTML Full Text PDF Full Text

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.

Saved in:
Bibliographic Details
Title: CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Authors: Thacker SG; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., McWilliams IL; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Bonnet B; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Halie L; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Beaucage S; Laboratory of Biological Chemistry; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Rachuri S; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Dey R; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Duncan R; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America., Modabber F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Robinson S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Bilbe G; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Arana B; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Verthelyi D; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Feb 28; Vol. 14 (2), pp. e0008050. Date of Electronic Publication: 2020 Feb 28 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32109251
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Thacker+SG%22">Thacker SG</searchLink>; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22McWilliams+IL%22">McWilliams IL</searchLink>; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Bonnet+B%22">Bonnet B</searchLink>; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Halie+L%22">Halie L</searchLink>; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Beaucage+S%22">Beaucage S</searchLink>; Laboratory of Biological Chemistry; Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Rachuri+S%22">Rachuri S</searchLink>; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Dey+R%22">Dey R</searchLink>; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Duncan+R%22">Duncan R</searchLink>; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Modabber+F%22">Modabber F</searchLink>; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Robinson+S%22">Robinson S</searchLink>; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bilbe+G%22">Bilbe G</searchLink>; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Arana+B%22">Arana B</searchLink>; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Verthelyi+D%22">Verthelyi D</searchLink>; Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101291488%22">PLoS neglected tropical diseases</searchLink> [PLoS Negl Trop Dis] 2020 Feb 28; Vol. 14 (2), pp. e0008050. <i>Date of Electronic Publication: </i>2020 Feb 28 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101291488 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-2735 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219352727%22">19352727 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Negl Trop Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32109251
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pntd.0008050
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0008050
    Titles:
      – TitleFull: CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Thacker SG
      – PersonEntity:
          Name:
            NameFull: McWilliams IL
      – PersonEntity:
          Name:
            NameFull: Bonnet B
      – PersonEntity:
          Name:
            NameFull: Halie L
      – PersonEntity:
          Name:
            NameFull: Beaucage S
      – PersonEntity:
          Name:
            NameFull: Rachuri S
      – PersonEntity:
          Name:
            NameFull: Dey R
      – PersonEntity:
          Name:
            NameFull: Duncan R
      – PersonEntity:
          Name:
            NameFull: Modabber F
      – PersonEntity:
          Name:
            NameFull: Robinson S
      – PersonEntity:
          Name:
            NameFull: Bilbe G
      – PersonEntity:
          Name:
            NameFull: Arana B
      – PersonEntity:
          Name:
            NameFull: Verthelyi D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2020 Feb 28
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1935-2735
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: PLoS neglected tropical diseases
              Type: main
ResultId 1